Manuscripts
Showing 1556 manuscripts.
Comparison of generic zidovudine + lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets
Citation
W. Keith Henry, Richard Brundage, Dennis Weller, Omobosola Akinsete, Anita Shet. Comparison of generic zidovudine + lamivudine (Cipla, Duovir) and the GlaxoSmithKline brand (Combivir) tablets. Journal of Acquired Immune Deficiency Syndromes. 2004. 35: 537.Year
2004
Journal
Journal of Acquired Immune Deficiency Syndromes
Psychiatric hospitalizations among children and youths with HIV infection
Citation
Denise Gaughan, Michael Hughes, James M. Oleske, Kay Malee, Carol Gore, Sharon Appelbaum Nachman. Psychiatric hospitalizations among children and youths with HIV infection. Pediatrics. 2004. 113: e44-e551. PMID: 15173535Year
2004
Journal
Pediatrics
A trial of three antiretroviral regimens in HIV-1 Infected Children
Citation
Katherine Ruiz Luzuriaga, Margaret McManus, Lynne M. Mofenson, Paula Britto, Bobbie Graham, John L. Sullivan. A trial of three antiretroviral regimens in HIV-1 Infected Children. New England Journal of Medicine. 2004. 350: 2471-80.Year
2004
Journal
New England Journal of Medicine
Long-Term Tolerability and Safety of Enfuvirtide for HIV-1 Infected Children.
Citation
Joseph A. Church, Michael Hughes, Paul Palumbo, Lynne M. Mofenson, Patricia Mastrodonato DeLora, Elizabeth (Betsy) Smith, Andrew A. Wiznia, Elizabeth Hawkins, Prakash Sista, Coleen K. Cunningham. Long-Term Tolerability and Safety of Enfuvirtide for HIV-1 Infected Children.. Pediatric Infectious Disease Journal. 2004. 23: 713-8.Year
2004
Journal
Pediatric Infectious Disease Journal
Study
P1005
Single Dose Pharmacokinetic of Enteric-Coated Didanosine in HIV-Infected Children
Citation
Jennifer R. King, Sharon Appelbaum Nachman, Ram Yogev, Janice Hodge, Grace M. Aldrovandi, Bharat Damle, Elizabeth (Betsy) Smith, Andrew A. Wiznia, Edward P. Acosta. Single Dose Pharmacokinetic of Enteric-Coated Didanosine in HIV-Infected Children. Antiviral Therapy. 2004. 7: 267-70.Year
2004
Journal
Antiviral Therapy
Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332
Citation
Sandra K. Burchett, Nancy Wade, Jashvant D. Unadkat, Sharon Huang, David E. Shapiro, Anita A. Mathias, Salih Yasin, Gregory Ciupak, Heather D. Watts, Issac Delke, Mobeen H. Rathore, Jane Hitti, Renee Samelson, Elizabeth (Betsy) Smith, Lynne M. Mofenson. Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332. Journal of Infectious Diseases. 2004. 190: 2167-74.Year
2004
Journal
Journal of Infectious Diseases
Pharmacokinetics and Safety of d4T in Combination with 3TC in HIV-infected Pregnant Women and Their Infants: Pediatric AIDS Clinical Trials Group Protocol 332.
Citation
Lisa M. Frenkel, Renee Samelson, Nancy Wade, Elizabeth Smith, Jashvant D. Unadkat, Lynne M. Mofenson, Sharon Huang, Sandra K. Burchett, David E. Shapiro, Anita Mathias, Salih Yasin, Gregory Ciupak, Salih Yasin, Gregory Ciupak, Heather D. Watts, Heather D. Watts, Issac Delke, Mobeen H. Rathore, Jane Hitti. Pharmacokinetics and Safety of d4T in Combination with 3TC in HIV-infected Pregnant Women and Their Infants: Pediatric AIDS Clinical Trials Group Protocol 332.. Journal of Infectious Diseases. 2004. 190: 2167-74.Year
2004
Journal
Journal of Infectious Diseases
Pharmacokinetics of Saquinavir Plus Low-Dose Ritonavir in HIV-Infected Pregnant Women.
Citation
Edward P. Acosta, Arlene D. Bardeguez, Carmen D. Zorrilla, Russell B. Van Dyke, Michael Hughes, Sharon Huang, Alice M. Stek, Jane Pitt, Heather Watts, Elizabeth Smith, Eleanor Jimenez, Lynne M. Mofenson. Pharmacokinetics of Saquinavir Plus Low-Dose Ritonavir in HIV-Infected Pregnant Women.. Antimicrobial Agents and Chemotherapy. 2004. 48: 430-436.Year
2004
Journal
Antimicrobial Agents and Chemotherapy
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy (HAART) in adolescents (age 12-22 years) infected through high-risk behavior.
Citation
Hulin Wu, Janet L. Lathey, Ping Ruan, Steven D. Douglas, Stephen A. Spector, Jane C. Lindsey, Michael Hughes, Bret J. Rudy, Patricia M. Flynn. Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy (HAART) in adolescents (age 12-22 years) infected through high-risk behavior.. Journal of Infectious Diseases. 2004. 189: 593-601.Year
2004
Journal
Journal of Infectious Diseases
The impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the U.S. in Pediatric AIDS Clinical Trials Group Protocol
Citation
Coleen K. Cunningham, Rajalaksh Balasubramanian, Issac Delke, Robert T. Maupin, Lynne M. Mofenson, Alejandro Dorenbaum, John L. Sullivan, Adolfo Gonzalez-Garcia, Edwin M. Thorpe, Richard D. Gelber. The impact of Race/Ethnicity on Mother-to-Child HIV Transmission in the U.S. in Pediatric AIDS Clinical Trials Group Protocol. Journal of Acquired Immune Deficiency Syndromes. 2004. 36: 800-807.Year
2004
Journal
Journal of Acquired Immune Deficiency Syndromes